This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

17 Aug 2011

Swiss Biopharma 4-Antibody Partners with HGS

Swiss firm 4-Antibody inked a collaboration agreement with Human Genome Sciences for the discovery and development of fully human antibodies.

Swiss biopharmaceutical firm 4-Antibody formed a collaboration Tuesday with Human Genome Sciences (HGS) to discover and develop fully human therapeutic antibodies.


The partnership, initially involving two projects, will focus on 4-Antibody’s proprietary high throughput in vitro Retrocyte Display technology for rapid discovery of fully human antibodies against new targets nominated by HGS.


This is 4-Antibody’s second alliance with a pharmaceutical partner. The first was agreed with Boehringer Ingelheim in 2010.


Robert Burns, 4-Antibody’s ceo, said: ‘Collaborations serve an important role in validating our Retrocyte Display technology platform and we’re deli

Related News